Fmoc-Cys(Et)-OH

Fmoc-Cys(Et)-OH is an Fmoc-protected cysteine derivative bearing an ethylthio substituent on the side chain, classifying it as a protected, sulfur-containing amino acid suitable for peptide-related synthesis. The molecule contains an Fmoc carbamate protecting group on the amino functional group and a free carboxylic acid, while the cysteine side chain is modified to a thioether (-S-CH2CH3) that changes nucleophilicity and provides a defined sulfur functionality. In synthetic workflows, this protected analogue is employed as a building block for stepwise peptide assembly where the Fmoc group supports controlled amine deprotection and the thioether side chain can be carried through sequence construction for subsequent chemical modification or labeling strategies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26648

CAS No:200354-34-3

Synonyms/Alias:200354-34-3;Fmoc-Cys(Et)-OH;Fmoc-S-ethyl-L-cysteine;L-Cysteine,S-ethyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;SCHEMBL1486194;CTK4E3104;ZINC2517139;AKOS015837242;RTR-009333;AK170053;TR-009333;(2R)-3-(ethylsulfanyl)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoicacid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C20H21NO4S
M.W/Mr.
371.46

Fmoc-Cys(Et)-OH is an Fmoc-protected cysteine derivative bearing an ethyl-substituted thiol side chain, presented as a carboxylic acid suitable for peptide building block workflows. The molecule contains a chiral cysteine backbone (retaining the stereogenic center at the alpha carbon), an Fmoc carbamate on the amino group for base-labile protection, and a thioether/thiol-equivalent side-chain functionality that can participate in sulfur chemistry after appropriate activation or conversion. The carboxylic acid enables standard amide bond formation at the C-terminus, while the ethylated sulfur substituent modulates nucleophilicity and oxidation sensitivity relative to unprotected cysteine. The combination of orthogonal protection and side-chain sulfur reactivity makes the compound a practical intermediate for controlled peptide coupling, thiol-masked manipulations, and downstream derivatization in synthetic and biochemical research contexts.

1. Peptide Synthesis

Fmoc-Cys(Et)-OH functions as an Fmoc-based cysteine building block for solid-phase peptide synthesis and solution-phase peptide assembly where orthogonal N-protection is required. The Fmoc carbamate enables iterative peptide coupling by protecting the amino functionality under standard conditions and then removing it with base to expose a reactive amine for subsequent coupling cycles. The carboxylic acid group participates in peptide bond formation, while the ethyl-substituted sulfur side chain can be carried through synthesis to manage chemoselectivity during chain elongation. The resulting peptidic products can be further processed for sulfur-state tuning, including conversion to thiol-reactive forms or incorporation into cysteine-dependent motifs for biochemical probes and peptidomimetic scaffolds. Fmoc-Cys(Et)-OH therefore supports peptide construction strategies that require stereochemically defined cysteine residues and controlled sulfur handling.

2. Side-Chain Functionalization

Fmoc-Cys(Et)-OH is used in amino acid derivatization and side-chain functionalization programs where sulfur chemistry is leveraged for conjugation-ready handles. The ethylated sulfur substituent provides a defined sulfur environment that can be transformed into more reactive thiol or thioether derivatives depending on the synthetic sequence, enabling selective labeling or crosslinking chemistry after peptide or small-molecule assembly. The Fmoc group allows the compound to be manipulated as a protected intermediate during derivatization planning, then removed when the free amine is needed for coupling or for generating conjugation targets. The carboxylic acid and protected amine also support incorporation into larger frameworks without premature interference from the side-chain sulfur. Downstream derivatives can include thiol-reactive intermediates for linker installation, sulfur-based cyclization precursors, or chemically defined cysteine analogs for structure-guided molecular design.

3. Chemical Biology Probes

Fmoc-Cys(Et)-OH serves chemical biology and biomolecular labeling workflows that require cysteine-positioned probes with controlled sulfur reactivity. The stereodefined cysteine backbone and Fmoc protection enable incorporation into peptides, peptide mimetics, or constrained scaffolds that mimic protein interaction motifs while maintaining a predictable attachment point for sulfur-mediated chemistry. The protected amine and carboxylic acid facilitate assembly of conjugatable sequences, and the ethyl-substituted sulfur side chain can be converted into labeling-ready sulfur species under appropriate conditions to support site-specific modifications. The resulting labeled constructs can be applied in studies of protein-ligand interactions, target engagement mapping, and mechanistic interrogation of cysteine-dependent processes using chemically defined reagents. Fmoc-Cys(Et)-OH thus aligns amino acid chemistry with probe synthesis needs for reproducible functional group placement and stereochemical consistency.

4. Peptidomimetics And SAR Studies

Fmoc-Cys(Et)-OH supports peptidomimetic construction and structure-activity relationship studies where cysteine analogs are incorporated as stereochemically defined building blocks. The Fmoc-protected amino group and terminal carboxylic acid allow rapid assembly of cysteine-containing analogs that can be diversified through side-chain sulfur conversions, enabling systematic variation of sulfur oxidation state, nucleophilicity, and conjugation behavior. The ethyl substitution on the sulfur can influence conformational preferences and reactivity patterns, which may be exploited when correlating structural changes with biological or binding outcomes reported in SAR programs. The protected intermediate format also helps maintain chemoselectivity during synthesis of analog libraries, including late-stage functional group installation after backbone assembly. Fmoc-Cys(Et)-OH therefore functions as a practical chiral amino acid derivative for generating defined cysteine-containing scaffolds used in medicinal chemistry and SAR-driven optimization.

5. Pharmaceutical Intermediate Preparation

Fmoc-Cys(Et)-OH is applicable to pharmaceutical intermediate preparation where protected amino acid derivatives are required for controlled synthesis of cysteine-containing intermediates and peptide-like building blocks. The Fmoc carbamate provides a robust N-protection strategy compatible with many peptide coupling and purification operations, while the carboxylic acid supports formation of amide-linked intermediates used in downstream synthesis. The ethyl-substituted sulfur side chain can be managed as a protected sulfur motif during manufacturing steps, allowing later conversion to a desired sulfur functionality for final API-related intermediates or process-defined derivatives. The stereogenic alpha carbon supports consistent stereochemical outcomes across batch manufacturing routes that depend on chiral building blocks. Fmoc-Cys(Et)-OH aligns with industrial process chemistry needs for reproducible protected amino acid handling and predictable downstream transformation to sulfur-functional targets.

6. Process Chemistry And Fine Chemical Synthesis

Fmoc-Cys(Et)-OH can be employed in process chemistry and fine chemical synthesis as a chiral intermediate for sulfur-containing nitrogenous frameworks. The combination of base-labile Fmoc protection and a carboxylic acid handle enables integration into scalable peptide coupling sequences and intermediate conversion steps that rely on predictable functional group interconversions. The sulfur substituent pattern can be selected to modulate oxidation sensitivity and chemoselectivity during manufacturing, supporting downstream derivatization steps that require controlled sulfur-state evolution. The compound's defined stereochemistry at the cysteine alpha position supports stereochemically consistent intermediate formation for subsequent transformations into larger molecules. Fmoc-Cys(Et)-OH therefore serves as a practical input for industrially relevant amino acid derivative synthesis where protected group strategy and sulfur reactivity management are central to reliable process design.

Size
1 g;5 g;25 g;
InChI
1S/C20H21NO4S/c1-2-26-12-18(19(22)23)21-20(24)25-11-17-15-9-5-3-7-13(15)14-8-4-6-10-16(14)17/h3-10,17-18H,2,11-12H2,1H3,(H,21,24)(H,22,23)/t18-/m0/s1
InChI Key
OUXUHWHQQLGDQE-SFHVURJKSA-N
Canonical SMILES
CCSCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesEpitope Mapping ServicesPeptide Modification ServicescGMP Peptide ServiceCustom Conjugation ServicePeptide Nucleic Acids SynthesisPeptide Synthesis ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers